Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: Candidate for peptide-based immunotherapy of Japanese cedar pollinosis

Allergology International

Volumn 58, Issue 1, 2009, Pages 63-70

  Masuyama, Keisuke ^a   Chikamatsu, Kazuaki ^a   Ikagawa, Shuji ^b   Matsuoka, Tomokazu ^a   Takahashi, Goro ^a   Yamamoto, Takanori ^a   Endo, Shuichiro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Shirafuji ENT Clinic   (Japan)

Author keywords

Cry j 1; Immunotherapy; Nasal allergy; Peptide; Th response

Indexed keywords

CRY J 1 ALLERGEN; GAMMA INTERFERON; INTERLEUKIN 4; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL ACTIVATION; CELL LINE; CELL STIMULATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MALE; NOSE ALLERGY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLLEN ALLERGY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 65449162969     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.08-OA-0008     Document Type: Article

References (23)

1. Nelson HS. Allergen immunotherapy: where is it now? J Allergy Clin Immunol 2007;119:769-77.
2. Durham SR. Allergen immunotherapy (desensitization) for allergic diseases. Clin Med 2006;6:348-51.
3. Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004; 113:1025-34.
4. Larche M. Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches. Pharmacol Ther 2005;108:353-61.
5. Larche M. Update on the current status of peptide immunotherapy. J Allergy Clin Immunol 2007;119:906-9.
6. Oldfield WLG, Kay AB, Larche M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol 2001;167:1734-9.
7. Oldfield WLG, Larche M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002; 360:47-53.
8. Alexander C, Tarzi M, Larche M et al. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy 2005; 60:1269-74.
9. Yasueda H, Yui Y, Shimizu T, Shida T. Isolation and partial characterization of major allergen from Japanese cedar (Cryptomeria japonica) pollen. J Allergy Clin Immunol 1983;71:77-86.
10. Sakaguchi M, Inouye S, Taniai M, Ando S, Usui M, Matuhasi T. Identification of the second major allergen of Japanese cedar pollen. Allergy 1990;45:309-12.
11. Sone T, Morikubo K, Shimizu K, Komiyama N, Tsunoo H, Kino K. Peptide specificity, HLA class II restriction, and T-cell subsets of the T-cell clones specific to either Cry j 1 or Cry j 2, the major allergens of Japanese cedar (Cryptomeria japonica) pollen. Int Arch Allergy Immunol 1999;119:185-96.
12. Sone T, Morikubo K, Miyahara M et al. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis. J Immunol 1998;161:448-57.
13. Ikagawa S, Matsushita S, Chen Y-Z, Ishikawa T, Nishimura Y. Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism. J Allergy Clin Immunol 1996;97:53-64.
14. Hori T, Kamikawaji N, Kimura A et al. Japanese cedar pollinosis and HLA-DP5. Tissue Antigens 1996;47:485-91.
15. Hirahara K, Tatsuta T, Takatori T et al. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens. J Allergy Clin Immunol 2001; 108:94-100.
16. Matsushita S, Muto M, Suemura M, Saito Y, Sasazuki T. HLA-linked nonresponsiveness to Cryptomeria japonica pollen antigen. I. Nonresponsiveness is mediated by antigen-specific suppressor T cell. J Immunol 1987;138: 109-15.
17. Griffith IJ, Lussier A, Garman R et al. Cloning of Cry j 1, the major allergen of Cryptomeria japonica (Japanese cedar) [abstract]. J Allergy Clin Immunol 1993;91:339.
18. Sone T, Komiyama N, Shimizu K et al. Cloning and sequencing of cDNA coding for Cry j 1, a major allergen of Japanese cedar pollen. Biochem Biophys Res 1994;199: 619-25.
19. Muller U, Akdis CA, Fricker M et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101: 747-54.
20. Fellrath JM, Kettner A, Dufour N et al. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol 2003; 111:854-61.
21. Gardner LM, O'Hehir RE, Rolland JM. High dose allergen stimulation of T cells from house dust mite-allergic subjects induces expansion of IFN-γ + T cells, apoptosis of CD4+IL-4+ T cells and T cell anergy. Int Arch Allergy Immunol 2004;133:1-13.
22. Cohn L, Homer RJ, Niu N et al. T helper 1 cells and interferon g regulate allergic airway inflammation and mucus production. J Exp Med 1999;190:1309-17.
23. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in Th1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 2002;295:338-42.